Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel Jindra

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 8, 2005
Factors affecting PBSC mobilization and collection in healthy donorsDaniel Lysák, Vladimír Koza, Pavel Jindra
Kidney & Blood Pressure Research|May 16, 2012
Pharmacoeconomic impact of different regimens to prevent cytomegalovirus infection in renal transplant recipientsLukas Kielberger, Mirko Bouda, Pavel Jindra, et al.
Journal of Clinical Medicine|June 2, 2021
Should We Stop Collecting the Preoperative Autologous Blood before Bone Marrow Harvest?Daniel Lysák, Lenka Hejretová, Marcela Hrabětová, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 20, 2014
Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatmentMonika Holubova, Daniel Lysak, Tomas Vlas, et al.
Journal of Clinical Apheresis|February 12, 2011
Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?Daniel Lysák, Zdeněk Kořístek, Zdeňka Gašová, et al.
Human Immunology|May 13, 2006
The replacement mutation in HLA-DRB1*1211 affects a likely keystone positionPeter A Horn, David S DeLuca, Pavel Jindra, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 1, 2013
In vitro testing of immunosupressive effects of mesenchymal stromal cells on lymphocytes stimulated with alloantigensDaniel Lysak, Tomas Vlas, Monika Holubova, et al.
Kidney & Blood Pressure Research|July 27, 2005
Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipientsTomás Reischig, Karel Opatrný, Vladislav Treska, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 27, 2014
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantationTomas Reischig, Martin Kacer, Pavel Jindra, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 13, 2002
A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantationTomas Reischig, Karel Opatrny, Mirko Bouda, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 8, 2005
Factors affecting PBSC mobilization and collection in healthy donorsDaniel Lysák, Vladimír Koza, Pavel Jindra
Kidney & Blood Pressure Research|May 16, 2012
Pharmacoeconomic impact of different regimens to prevent cytomegalovirus infection in renal transplant recipientsLukas Kielberger, Mirko Bouda, Pavel Jindra, et al.
Journal of Clinical Medicine|June 2, 2021
Should We Stop Collecting the Preoperative Autologous Blood before Bone Marrow Harvest?Daniel Lysák, Lenka Hejretová, Marcela Hrabětová, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 20, 2014
Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatmentMonika Holubova, Daniel Lysak, Tomas Vlas, et al.
Journal of Clinical Apheresis|February 12, 2011
Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?Daniel Lysák, Zdeněk Kořístek, Zdeňka Gašová, et al.
Human Immunology|May 13, 2006
The replacement mutation in HLA-DRB1*1211 affects a likely keystone positionPeter A Horn, David S DeLuca, Pavel Jindra, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 1, 2013
In vitro testing of immunosupressive effects of mesenchymal stromal cells on lymphocytes stimulated with alloantigensDaniel Lysak, Tomas Vlas, Monika Holubova, et al.
Kidney & Blood Pressure Research|July 27, 2005
Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipientsTomás Reischig, Karel Opatrný, Vladislav Treska, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 27, 2014
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantationTomas Reischig, Martin Kacer, Pavel Jindra, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 13, 2002
A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantationTomas Reischig, Karel Opatrny, Mirko Bouda, et al.
Pageof 9